New study tests Real-World relief for debilitating endometriosis pain
NCT ID NCT07440043
Summary
This study aims to see how well a medication called relugolix combination therapy works for reducing pelvic pain caused by endometriosis in everyday medical practice. It will observe 33 women with confirmed endometriosis who are already taking this medication for 24 weeks. The main goal is to measure changes in their pain levels and other symptoms to provide real-world evidence for doctors and patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.